Thursday, November 4, 2021
President & CEO, CBRE
G. Mason Morfit
Partner, CEO and CIO, ValueAct Capital, member of the Management Committee
Senior Editor, Bloomberg Live
Deputy New York Bureau Chief
Bob Sulentic has been President & Chief Executive Officer of CBRE Group, Inc. since December 2012. CBRE is the world's largest commercial real estate services and investment firm, with 2020 revenues of $23.8 billion and more than 100,000 employees serving clients in more than 100 countries.
CBRE is ranked #122 on the Fortune 500 and has been a Fortune Most Admired Company for nine consecutive years, including 2021 when it was ranked #1 in the real estate sector for the third consecutive year.
Prior to becoming CEO, Mr. Sulentic served as President of CBRE, with responsibility for all business segments. In addition, he served as the company's Chief Financial Officer in 2009, during the depth of the global financial crisis. Earlier, Mr. Sulentic served as Group President for CBRE's EMEA, Asia Pacific, and Development Services businesses.
Mr. Sulentic began his real estate career with Trammell Crow Company in 1984 as an Industrial Leasing Agent in Houston, Texas. Throughout the next 23 years he served in various leadership positions, including Project Partner, Divisional Partner, Managing Director and CFO. Mr. Sulentic was elected President and CEO of Trammell Crow Company in October 2000, and he became Chairman of the Board in April 2002. He served in those roles when Trammell Crow Company merged with CBRE in late 2006.
Mr. Sulentic is a member of the CBRE Group, Inc. Board of Directors and serves as Chair of CBRE Acquisition Holdings, Inc., a CBRE-sponsored Special Purpose Acquisition Company (SPAC) that launched in December 2020. He also serves on the Board of Directors of Industrious, a leading provider of premium flexible workplace solutions; CBRE is Industrious' largest shareholder. He also served as the independent Chairman of the Board of Staples, Inc. until its acquisition by Sycamore Partners, a private equity firm, in September 2017.
Mr. Sulentic received an M.B.A. from Harvard Business School and a B.A. in Computer Science from Iowa State University. Mr. Sulentic founded and chairs a private foundation that supports various charitable endeavors by providing direct grants to third-party organizations as well as executing its own initiatives.
G. Mason Morfit
G. MASON MORFIT is a Partner, the Chief Executive Officer and Chief Investment Officer of ValueAct Capital and is a member of the firm's Management Committee. Mr. Morfit is a former director of Advanced Medical Optics, Inc., C.R. Bard, Inc., Immucor, Inc., Microsoft Corporation, MSD Performance, Inc., Solexa, Inc. and Valeant Pharmaceuticals International. Prior to joining ValueAct Capital at inception, Mr. Morfit worked in equity research for Credit Suisse First Boston's health care group where he focused on the managed care industry.
Mr. Morfit has lectured on issues of corporate governance and executive compensation at Stanford Law School's Director's College, the Graduate School of Business at Stanford University, and the Haas School of Business at the University of California, Berkeley. Mr. Morfit is a member of the Advisory Council for Princeton University's Woodrow Wilson School of Public and International Affairs and serves on the Board of Directors of the Tipping Point Community. He has a B.A. from Princeton University and is a CFA charterholder.